| Title |
Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers
|
|---|---|
| Published in |
Psychopharmacology, November 2009
|
| DOI | 10.1007/s00213-009-1704-3 |
| Pubmed ID | |
| Authors |
David Ted George, David W. Herion, Cheryl L. Jones, Monte J. Phillips, Jacqueline Hersh, Debra Hill, Markus Heilig, Vijay A. Ramchandani, Christopher Geyer, David E. Spero, Erick D. Singley, Stephanie S. O’Malley, Raafat Bishai, Robert R. Rawlings, George Kunos |
| Abstract |
There is an extensive literature showing that the CB(1) cannabinoid receptor antagonist rimonabant (SR141716) decreases alcohol consumption in animals, but little is known about its effects in human alcohol drinkers. |
Mendeley readers
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 1% |
| Unknown | 66 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 18 | 27% |
| Student > Ph. D. Student | 15 | 22% |
| Student > Bachelor | 9 | 13% |
| Student > Doctoral Student | 4 | 6% |
| Student > Master | 4 | 6% |
| Other | 9 | 13% |
| Unknown | 8 | 12% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 24% |
| Psychology | 10 | 15% |
| Biochemistry, Genetics and Molecular Biology | 7 | 10% |
| Neuroscience | 6 | 9% |
| Agricultural and Biological Sciences | 5 | 7% |
| Other | 10 | 15% |
| Unknown | 13 | 19% |